What Researchers Did
Researchers assessed whether HBOT improved bone healing in four non-diabetic patients undergoing maxillary sinus augmentation for dental implants, and confirmed findings in a diabetic mouse model.
What They Found
HBOT improved bone formation markers including VEGF, BMP-2, and osteocalcin in human patients treated for 5, 6, or 9 weeks. In diabetic mice, HBOT reversed impaired bone healing through activation of the Nrf2 antioxidant pathway.
What This Means for Canadian Patients
Diabetic patients undergoing dental implant procedures face elevated risk of poor bone healing. This study supports HBOT as an adjunct to implant surgery in diabetic patients, a clinically relevant finding for Canadian dental and oral surgery practice.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The human component involved only four patients, and the mouse model may not fully replicate complex diabetic bone healing in people.